FDA chief resigns amid agency turmoil, signaling leadership shake-up
TL;DR Summary
FDA Commissioner Marty Makary resigned amid months of internal turmoil at the agency, with a plan to replace him approved by the White House. Kyle Diamantas will serve as acting leader, as the shake-up at the Department of Health and Human Services continues to unfold.
- FDA chief Marty Makary resigns amid agency turmoil The Washington Post
- Marty Makary departs FDA after clashes with Trump over fruit-flavored vapes The Guardian
- F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure The New York Times
- Trump's FDA chief is out after angering pharma CEOs, vaping lobbyists and anti-abortion activists AP News
- Makary’s time atop FDA over, Diamantas named acting commissioner Politico
Reading Insights
Total Reads
0
Unique Readers
6
Time Saved
21 min
vs 22 min read
Condensed
99%
4,247 → 45 words
Want the full story? Read the original article
Read on The Washington Post